Bin Jiang
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Genetics top 10%
- Mesenchymal stem cell research
Papers in
- Co-authors
- Zhaolai Ma (18 shared papers)Dianrong Xiu (19 shared papers)Chunhui Yuan (14 shared papers)Lianyuan Tao (6 shared papers)Ren‐He Xu (5 shared papers)Enqin Li (4 shared papers)Zhenwu Zhang (3 shared papers)Ming Tao (7 shared papers)
In The Last Decade
Bin Jiang
58 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 74
- Hepatology 160
- Genetics 124
- Oncology 279
- Complementary and alternative medicine 45
- Rehabilitation 29
Countries citing papers authored by Bin Jiang
This map shows the geographic impact of Bin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Jiang more than expected).
Fields of papers citing papers by Bin Jiang
This network shows the impact of papers produced by Bin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Jiang. The network helps show where Bin Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 194 | |
| 2 | 2020 | 88 | |
| 3 | 2018 | 66 | |
| 4 | 2015 | 56 | |
| 5 | 2021 | 52 | |
| 6 | 2019 | 45 | |
| 7 | 2019 | 45 | |
| 8 | 2016 | 41 | |
| 9 | 2018 | 40 | |
| 10 | 2016 | 35 | |
| 11 | 2015 | 31 | |
| 12 | 2023 | 27 | |
| 13 | 2017 | 26 | |
| 14 | 2019 | 26 | |
| 15 | 2020 | 26 | |
| 16 | 2018 | 25 | |
| 17 | 2016 | 24 | |
| 18 | 2021 | 20 | |
| 19 | 2018 | 19 | |
| 20 | 2021 | 17 |
About Bin Jiang
Bin Jiang is a scholar working on Oncology, Genetics, Hepatology, Epidemiology and Immunology, having authored 65 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Mesenchymal stem cell research (5 papers), Neuroendocrine Tumor Research Advances (5 papers), Immune cells in cancer (4 papers), Hepatitis B Virus Studies (3 papers), Lung Cancer Treatments and Mutations (2 papers) and Teleoperation and Haptic Systems (2 papers). The work is most often cited by research in Hepatology (160 citations), Genetics (124 citations), Oncology (279 citations), Complementary and alternative medicine (45 citations) and Rehabilitation (29 citations). Bin Jiang has collaborated with scholars based in China, Macao and Germany. Frequent co-authors include Zhaolai Ma, Dianrong Xiu, Chunhui Yuan, Lianyuan Tao, Ren‐He Xu, Enqin Li, Zhenwu Zhang, Ming Tao, Lingfu Zhang and Hangyan Wang. Their work appears in journals such as Medicine, Cancer Management and Research, Frontiers in Oncology, World Journal of Surgical Oncology and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.